GCR Interactive: Pharmaceuticals - Collision of Biologics | McDermott Skip to main content

GCR Interactive: Pharmaceuticals – Collision of Biologics

GCR Interactive: Pharmaceuticals – Collision of Biologics

Überblick


With the biologics market a growing focus of development across the globe, what role does antitrust have to play in order to ensure healthy price competition between reference-priced biologics and competing biosimilars?

Hendrik Viaene speaks in this session which will focus on this role, and what lessons can and cannot be learned from generics, to help ensure low cost versions are available to all.

Moderator
David Giardina, Sidley Austin

Panel
Sheng Li, NERA Economic Consulting
Elaine Johnston, Allen & Overy
Hendrik Viaene, McDermott, Will & Emery

For more information, and to register, please click here.

Mehr erfahren

Webinar / Webinar / October 8, 2025

Global Antitrust Update | Webinar Series - Fall 2025

Brussels, Belgium / CompLaw: Advanced EU Brussels / November 27, 2024

CompLaw: EU Advanced, Brussels: Managing Multi-Jurisdictional Mergers: Practical Perspectives

Webinar / In-person / November 19, 2024

Global Antitrust Update | Webinar Series - Winter 2024

Webinar / In-person / September 12, 2024

Global Antitrust Update | Webinar Series - Fall 2024

Ansprechpartner